What is the treatment for a Staphylococcus (Staph) infection in the nares?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Staphylococcus Infection in the Nares

For active staph infection in the nares, treat with mupirocin 2% ointment applied to both anterior nares twice daily for 5-10 days, combined with appropriate systemic antibiotics if there are signs of invasive infection. 1, 2

Distinguishing Active Infection from Colonization

  • Active infection presents with purulent drainage, crusting, pain, erythema, or systemic signs (fever, malaise), requiring antimicrobial treatment 1
  • Asymptomatic colonization (positive nasal swab without symptoms) does not require routine treatment unless specific criteria are met 2, 3

Treatment for Active Nasal Staph Infection

Topical Therapy

  • Apply mupirocin 2% ointment to both anterior nares twice daily for 5-10 days as the primary topical agent 2, 3, 4
  • Mupirocin is bactericidal against S. aureus (including MRSA) and works by inhibiting bacterial protein synthesis through a unique mechanism with no cross-resistance to other antimicrobials 4, 5
  • The medication achieves high local concentrations with minimal systemic absorption (<1.1 ng/mL in whole blood) 4

Systemic Antibiotics (When Indicated)

  • Add systemic antibiotics if there is extensive surrounding cellulitis, fever, or systemic manifestations of infection 1
  • For MSSA infections with systemic involvement: nafcillin 1-2 g IV every 4-6 hours (adults) or 50 mg/kg/dose (pediatrics) 1
  • For MRSA infections with systemic involvement: vancomycin, linezolid, daptomycin, or ceftaroline based on severity 1
  • Duration of systemic therapy is typically 5-7 days depending on clinical response 1

Decolonization for Recurrent Infections

Decolonization should only be pursued in patients with documented recurrent staph skin infections despite optimized hygiene, or ongoing household transmission—not for simple colonization. 2, 3

Decolonization Protocol

  • Mupirocin 2% ointment to anterior nares twice daily for 5-10 days 2, 3
  • Add chlorhexidine gluconate 2% body wash daily for 5-14 days, OR dilute bleach baths (¼-½ cup bleach per full bathtub or 1 teaspoon per gallon) for 15 minutes twice weekly for up to 3 months 2, 3
  • Concurrent measures: keep wounds covered with clean dry bandages, practice hand hygiene after touching infected areas, avoid sharing personal items, clean high-touch surfaces regularly 3
  • Treat interdigital toe space infections/maceration to eliminate colonization reservoirs 3

Household Contact Management

  • Evaluate and treat symptomatic household contacts for active infection first 2, 3
  • Consider decolonization of asymptomatic household contacts only when ongoing transmission is documented despite hygiene measures 2, 3
  • Treating both patient and household contacts together results in fewer recurrences than treating the patient alone 3

Alternative Agents (When Mupirocin Unavailable or Resistant)

  • Povidone-iodine nasal antiseptic preparations show efficacy against mupirocin-resistant MRSA with rapid antimicrobial activity within 1 hour 6
  • Chlorhexidine/neomycin (Naseptin) cream is less effective than mupirocin, with only 61% eradication at 8 days versus 95% with mupirocin, and higher recolonization rates (89% versus 43%) 7

Important Caveats and Pitfalls

  • Do not use mupirocin for simple nasal trauma or cuts without signs of infection—this promotes resistance without clinical benefit 8
  • Avoid routine surveillance cultures post-decolonization in the absence of active infection 2, 3
  • High-level mupirocin resistance (MIC >1024 mcg/mL) has been reported; prolonged or indiscriminate use should be avoided 3, 4
  • Recolonization is common after decolonization therapy, occurring in 40-60% of patients within 3 months, often with exogenous strains 9, 7
  • Extranasal carriage sites (pharynx, perineum, axillae, groin) are common (19-23% prevalence) and mupirocin is less effective at clearing these sites, contributing to treatment failure 9
  • Do not use hexachlorophane in children under 2 months due to neurological complications 2
  • Mupirocin effectively reduces nasal colonization but has not conclusively been shown to prevent infections in community settings 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Asymptomatic MRSA Nasal Colonization

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of MRSA Nasal Colonization

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Overview of the role of mupirocin.

The Journal of hospital infection, 1991

Guideline

Mupirocin Prescribing Guidelines for Nasal Cuts

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.